Logo Image
|Webcasts|April 13, 2021

Best Practices for Building a Successful Clinical Oversight Function

*** Tuesday, April 13, 2021 at 11am EDT| 8am PDT | 4pm BST | 5pm CEST *** In this webcast, we will explore best practices for building an effective Clinical Oversight function using a variety of different delivery models. *** On demand available after final airing until Apr. 13, 2022 ***

Register free: http://www.appliedclinicaltrialsonline.com/act_w/clinical_oversight

Event Overview:
Clinical oversight contributes to the success of global trials by ensuring the protection of trial participants as well as the integrity of the data collected. Global regulators are increasingly seeking more formal documentation of sponsor oversight activities during inspections.

Sponsors who are not involved in their clinical oversight processes, or who follow informal documentation strategies, run the risk of inspection findings (e.g., FDA-483) that can cause delays, fines, and potentially impact regulatory approvals. When sponsors choose to outsource this critical function, the pros and cons must be carefully considered.

Key Learning Objectives:

In this webcast you will:

  1. Learn about the background of clinical oversight, including current global regulations, implications of COVID-19, decentralized trials, and more
  2. Understand the importance of the sponsor/CRO relationship when executing oversight activities, including the difference between quality vs monitoring vs oversight
  3. Learn best practices for sponsors who are planning c linical oversight activities but may be unsure whether keeping this function in-house is more efficient than outsourcing
  4. Explore how sponsors can leverage alternative delivery models to help mitigate risks and streamline processes

Speakers: Nan Croy, Director of Functional Service Solutions, Advanced Clinical

Melissa Mauriber, Vice President, Clinical Operations Quality & Talent Development, Advanced Clinical

Sponsor: Advanced Clinical

Time and Date: Tuesday, April 13, 2021 at 11am EDT| 8am PDT | 4pm BST | 5pm CEST

On demand available after final airing until Apr. 13, 2022

Register free: http://www.appliedclinicaltrialsonline.com/act_w/clinical_oversight

Related to this article

View more
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.
Read more
What the Epilepsy Community Has Taught Us About Trial Feasibility
What the Epilepsy Community Has Taught Us About Trial Feasibility
In this video interview, Amélie Lothe, global medical community head for rare epilepsies at UCB Pharma, shares what she has learned firsthand from families living with Dravet syndrome and CDKL5 deficiency disorder about what makes trial participation possible—and what makes it not.
Read more